Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

312 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High precision in epileptic seizure self-reporting with an app diary.
Zabler N, Swinnen L, Biondi A, Novitskaya Y, Schütz E, Epitashvili N, Dümpelmann M, Richardson MP, Van Paesschen W, Schulze-Bonhage A, Hirsch M. Zabler N, et al. Sci Rep. 2024 Jul 9;14(1):15823. doi: 10.1038/s41598-024-66932-y. Sci Rep. 2024. PMID: 38982283 Free PMC article.
A multicenter registry study of the CD38 antibody daratumumab for the treatment of microvascular inflammation following kidney transplantation.
Drasch T, Mayer KA, Böhmig GA, Akifova A, Halleck F, Budde K, Rohlfing D, Hinze C, Kluger M, Grahammer F, Kowald J, Baatz S, Reuter S, Kemmner S, Seibt T, Pigorsch M, Beck J, Bornemann-Kolatzki K, Schütz E, Oellerich M, Banas B, Zecher D. Drasch T, et al. Among authors: schutz e. Kidney Int. 2026 Jul 23:S0085-2538(26)00604-6. doi: 10.1016/j.kint.2026.06.033. Online ahead of print. Kidney Int. 2026. PMID: 42492852 Free article.
Prolonged CD38 targeting with felzartamab in antibody-mediated kidney transplant rejection: a biomarker-guided open-label phase 2 extension.
Mayer KA, Diebold M, Schrezenmeier EV, Halloran PF, Haindl S, Schatzl M, Akifova A, Allmer DM, Schranz S, Kozakowski N, Kläger J, Amann K, Beck J, Schütz E, Naesens M, Loupy A, Raynaud M, Görzer I, Vietzen H, Ingle G, Flesher DL, Patel UD, Halleck F, Graf I, Jilma B, Budde K, Böhmig GA. Mayer KA, et al. Among authors: schutz e. Lancet Reg Health Eur. 2026 Jul 9;68:101768. doi: 10.1016/j.lanepe.2026.101768. eCollection 2026 Sep. Lancet Reg Health Eur. 2026. PMID: 42471965 Free PMC article.
312 results